Coronavirus particles, illustration. Today the governing Board of the California Institute for Regenerative Medicine (CIRM) approved new clinical trials for COVID-19 and sickle cell disease (SCD) and two earlier stage projects to develop therapies for COVID-19. Dr. Michael Mathay, of the University of California at San Francisco, was awarded $750,000 for a clinical trial testing … Continue reading CIRM Board Approves Clinical Trials Targeting COVID-19 and Sickle Cell Disease
University of Southern California
Huge honor, hugely deserved for CIRM-funded stem cell researcher
Dr. Andy McMahon: Photo courtesy USC Andy McMahon is one of the most understated, humble and low-key people you are ever likely to meet. He’s also one of the smartest. And he has a collection of titles to prove it. He is the W.M. Keck Provost and University Professor in USC’s departments of Stem Cell … Continue reading Huge honor, hugely deserved for CIRM-funded stem cell researcher
Helping the blind see – mice that is
When I first saw the headline for this story I thought of the nursery rhyme about the three blind mice. Finally, they’ll be able to see the farmer’s wife coming at them with a carving knife. But the real-world implications are of this are actually pretty exciting. Researchers at the National Institute of Health’s National … Continue reading Helping the blind see – mice that is
Facebook Live: Ask the Stem Cell Team
On December 12th we hosted our latest 'Facebook Live: Ask the Stem Cell Team' event. This time around we really did mean team. We had a host of our Science Officers answering questions from friends and supporters of CIRM. We got a lot of questions and didn't have enough time to address them all. So … Continue reading Facebook Live: Ask the Stem Cell Team
USC study shows how tumor cells in the bloodstream can target distant organs
Various types of cancer can become particularly aggressive and difficult to treat once they spread from their initial point of origin to other parts of the body. This unfortunate phenomenon, known as metastasis, can make treatment very challenging, decreasing the chance of survival for the patient. In order to better understand this process, a CIRM … Continue reading USC study shows how tumor cells in the bloodstream can target distant organs
Predicting the Impact of Stem Cell Cures on Healthcare Burden in California
A new independent report says developing stem cell treatments and cures for some of the most common and deadly diseases could produce multi-billion dollar benefits for California in reduced healthcare costs and improved quality and quantity of life. The report, by researchers at the University of Southern California’s Leonard D. Schaeffer Center for Health Policy … Continue reading Predicting the Impact of Stem Cell Cures on Healthcare Burden in California
New Report Says CIRM Produces Big Economic Boost for California
An independent Economic Impact Report says the California Institute for Regenerative Medicine (CIRM) has had a major impact on California’s economy, creating tens of thousands of new jobs, generating hundreds of millions of dollars in new taxes, and producing billions of dollars in additional revenue for the state. The report, done by Dan Wei and … Continue reading New Report Says CIRM Produces Big Economic Boost for California
Scientists at USC untangle the mysteries of cellular reprogramming- a method that could be used to treat diseases
Dr. Justin Ichida, Assistant Professor at USC and lead author of the study Scientists have long tried to repurpose cells in order to potentially treat various types of conditions. This process, called reprogramming, involves changing one type of cell into another, such as a blood cell into a muscle cell or nerve cell. Although the … Continue reading Scientists at USC untangle the mysteries of cellular reprogramming- a method that could be used to treat diseases
CIRM Board Approves $19.7 Million in Awards for Translational Research Program
In addition to approving funding for breast cancer related brain metastases last week, the CIRM Board also approved an additional $19.7 million geared towards our translational research program. The goal of this program is to help promising projects complete the testing needed to begin talking to the US Food and Drug Administration (FDA) about holding … Continue reading CIRM Board Approves $19.7 Million in Awards for Translational Research Program
Regulated, reputable, and reliable – distinguishing legitimate clinical trials from predatory clinics
Here at CIRM, we get calls every day from patients asking us if there are any trials or therapies available to treat their illness or an illness affecting a loved one. Unfortunately, there are some predatory clinics that try to take advantage of this desperation by advertising unproven and unregulated treatments for a wide range … Continue reading Regulated, reputable, and reliable – distinguishing legitimate clinical trials from predatory clinics
The Stem Cellar 